Skip to main content
Pharmaron Beijing Co., Ltd. logo

Pharmaron Beijing Co., Ltd. — Investor Relations & Filings

Ticker · 300759 ISIN · CNE100003JW4 LEI · 300300JYXHGVS5SNGG54 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2025-10-28 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300759

About Pharmaron Beijing Co., Ltd.

https://www.pharmaron.cn

Pharmaron Beijing Co., Ltd. is a premier R&D service provider for the life sciences industry, offering a comprehensive, fully integrated platform for drug discovery, development, and manufacturing. The company supports global pharmaceutical and biotechnology partners through a wide range of services, including laboratory chemistry, biology, DMPK, pharmacology, and safety assessment. Its capabilities extend to clinical development services and commercial-scale manufacturing for small molecules, biologics, and cell and gene therapies. By leveraging advanced technology and a global network of facilities, the company facilitates the transition of drug candidates from initial concept to market approval, optimizing the efficiency and success of the drug development lifecycle.

Recent filings

Filing Released Lang Actions
《累积投票制实施细则》（2025年10月）
Governance Information Classification · 95% confidence The document is titled as implementation rules for cumulative voting system for board director elections at a company. It details governance procedures related to shareholder voting rights and election methods for directors. There is no financial data, no report or announcement of financial results, no regulatory filing or certification, and no mention of meetings or voting results. The content is focused on governance rules and internal company procedures regarding board elections. This fits the definition of Governance Information (CGR), which covers the company's internal rules, board structure, and governance practices. The document length is short but contains substantive governance content, not just an announcement or notice. Therefore, the appropriate classification is CGR with high confidence.
2025-10-28 Chinese
《对外担保管理制度》（2025年10月）
Governance Information Classification · 95% confidence The document is titled '对外担保管理制度' which translates to 'External Guarantee Management System' and details the company's internal policies and procedures for managing external guarantees, including approval authorities, application procedures, contract management, risk control, disclosure obligations, and responsibilities of personnel. It references compliance with company law, securities exchange listing rules, and company articles of association. The document is a governance or internal control policy document rather than a financial report, earnings release, or announcement. It does not contain financial statements, audit opinions, or regulatory filings. It is not a report publication announcement or a certification. The content aligns with governance information about internal rules and management practices related to external guarantees. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 4769 characters, sufficient for a substantive policy document.
2025-10-28 Chinese
第三届监事会第十四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Kanglong Huacheng (Beijing) New Drug Technology Co., Ltd. It details the meeting held on October 28, 2025, including approval of the 2025 third quarter report, amendments to the company bylaws, and a significant acquisition transaction. The document references the 2025 third quarter report but does not contain the report itself or detailed financial statements. It is a formal announcement of meeting resolutions and approvals rather than a full financial report or detailed management discussion. The document length is short (1763 characters), and it serves as an official meeting resolution announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such announcements that do not fit other specific categories.
2025-10-28 Chinese
《董事会议事规则》（2025年10月）
Governance Information Classification · 100% confidence The document is titled "董事会议事规则" which translates to "Board Meeting Rules" or "Rules of Procedure for the Board of Directors." It details the governance framework, procedures for convening board meetings, proposal submission, voting, attendance, confidentiality, and record-keeping. It references relevant laws and listing rules but does not contain financial data, audit results, or report disclosures. It is a governance document outlining internal board rules rather than a report or announcement of financial results or management changes. Therefore, it fits the category of Governance Information (CGR). The document length (5898 characters) and content confirm it is a full governance rules document, not a brief announcement or certification.
2025-10-28 Chinese
《投资者关系管理制度》（2025年10月）
Governance Information Classification · 95% confidence The document is titled '投资者关系管理制度' which translates to 'Investor Relations Management System'. It outlines the company's policies and procedures for managing investor relations, including communication principles, organizational responsibilities, and compliance with laws and regulations. There are no financial statements, earnings data, or specific report disclosures. The document is a governance-related policy document rather than a financial report or announcement. It is not a report publication announcement since it is substantive and not merely announcing a report. It fits best under Governance Information (CGR) as it details internal rules and governance practices related to investor relations management.
2025-10-28 Chinese
《内部审计管理制度》（2025年10月）
Governance Information Classification · 95% confidence The document is titled '内部审计管理制度' which translates to 'Internal Audit Management System' and details the internal audit policies, responsibilities, procedures, and quality control within the company. It is a comprehensive internal governance document focused on internal audit management rather than financial results, shareholder information, or external reporting. It does not contain financial statements or earnings data, nor is it an announcement or certification. It is a governance-related document outlining internal audit rules and practices, which fits best under Governance Information (CGR).
2025-10-28 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.